Skip to main content
logo
Avenue Therapeutics, Inc. (ATXI)
OTCMKTS · Delayed Price · Currency is USD
0.4300
+0.0100 (2.38%)
At close: Oct 14, 2026

Avenue Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-1.4----
Revenue Growth
------
Gross Profit
-1.4----
Operating Income
-3.1-3.29-11.28-14.54-8.04-3.74
Net Income
-2.78-2.91-11.65-10.38-3.55-3.73
Earnings Per Share
-0.86-0.93-9.00-73.48-121.92-246.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.942.862.591.786.713.76
Total Debt
------
Net Cash (Debt)
1.942.862.591.786.713.76
Net Cash Growth
-41.61%10.06%45.48%-73.42%78.26%20.15%
Net Cash Per Share
0.600.912.0012.63230.24249.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.38-1.83-9.03-9.45-7.6-3.75
Free Cash Flow
-1.38-1.83-9.03-9.45-7.6-3.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%----
Operating Margin
--234.05%----
Pretax Margin
--209.90%----
Profit Margin
--207.19%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1.54----